Anuradha Roy, PhD

Dr. Roy has over 25 years of early drug discovery experience in both academia and biopharma. She has performed numerous target-based biochemical, cell-based reporter and phenotypic screens, including drug repositioning and combination screens across various fields of study (cancer, anti-infectives, neurodegenerative disorders, rare diseases, bioprospecting). Dr. Roy has extensive experience with assay design, development & optimization utilizing all available assay platform technologies, analyzing large data sets, and routinely supports medicinal chemistry efforts in hit identification and probe/hit/lead optimization.